SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending as investors weigh significant trading volume and growth metrics ahead of quarterly earnings, with the community fiercely debating the impact of potential PDT rule changes and the company's competitive positioning. While some shareholders are betting on a massive breakout driven by product innovation and AI integration, others remain skeptical, pointing to rising operating expenses and a history of volatility surrounding earnings reports.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh the significance of federal funding commitments and government equity stakes against concerns regarding high cash burn and revenue growth. Community sentiment remains polarized, with active debates centered on whether recent technical developments justify the company's valuation or if the stock is facing a deeper correction driven by volatility and dilution fears.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing massive momentum as one of nine companies selected by the U.S. government for a strategic $100 million investment and equity partnership to bolster domestic quantum infrastructure. The market is actively discussing the company's valuation gap compared to its peers, with community members highlighting its zero-debt balance sheet, partnership with NVIDIA, and revenue-generating potential in quantum sensing and defense as key drivers for long-term growth.

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is trending due to reports of breakthrough preclinical data for its AKTX-101 ADC payload, which shows synergistic potential when paired with KRAS inhibitors in pancreatic cancer models. While some investors see this as a key step toward future clinical trials and a potential pipeline pivot, the community remains divided, with many expressing long-term frustration over historic dilution, reverse splits, and the company's ability to successfully monetize its intellectual property.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is experiencing significant volatility and intense community discussion following a strong earnings report that highlighted unexpected profitability, improved margins, and aggressive delivery guidance. While retail investors are actively sharing petitions and calling for investigations into alleged market manipulation and algorithmic shorting, the broader community remains divided between those capitalizing on the dip and those frustrated by the disconnect between the company's growth metrics and its recent share price performance.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing market attention following a significant government funding announcement that includes direct federal grants and equity participation. Investors and community members are actively debating the long-term strategic viability of the quantum sector, with discussions weighing the impact of federal validation against concerns over cash burn and potential dilution.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending as investors weigh strong quarterly earnings and AI-driven growth against cautious forward guidance, fueling intense debate over the company's long-term resilience against AI disruption. Community members are actively analyzing the stock's recent volatility and leadership transitions, with many debating whether the current valuation offers a recovery opportunity or signals further downside for the broader enterprise software sector.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor Corp. is capturing significant investor attention following a double-beat earnings report that featured raised guidance and a massive expansion of its share buyback program. While the stock has seen volatile price action, the community is actively debating the effectiveness of these shareholder-friendly measures against ongoing concerns about competitive pressure in the footwear market and potential tariff-related headwinds.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently trading at a high valuation as investors debate its role as a defensive hedge against inflation and rising fuel costs, with sentiment split between those capitalizing on its retail dominance and those concerned that its premium earnings multiple is disconnected from slowing consumer discretionary spending.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. is trending following the announcement of a multi-year, nine-figure AI compute infrastructure contract with a major investment-grade customer, which community members view as a significant validation of the company's capital-efficient business model. Traders are actively discussing the stock as a 'proxy play' for the upcoming Cerebras Systems IPO, with many highlighting its low float, technical momentum, and strategic position in the AI data center infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NRXP With all the FUD trying to convince people of how hard it will be to sell Ketafree (while trying hard to ignore inconveniently bullish information about that), you&#39;d think NRXP didn&#39;t have a board member who personally played a key role in growing Teva&#39;s generics business into a behemoth. 🤷

Matthew Becker

Hackabull

StockTwits Web

NRX Pharmaceuticals Inc

 With all the FUD trying to convince people of how hard it will be to sell Ketafree (while trying hard to ignore inconveniently bullish information about that), you'd think NRXP didn't have a board member who personally played a key role in growing Teva's generics business into a behemoth. 🤷

David G

@DavidBG so many successful FDA approvals end up not working out as intended look at ICU for an example of that.  I know it’s a medical device versus what NRXP is doing.  Addressable market doesn’t guarantee an approval results in capturing the that entire market.  Too many variables to understand exact market share post award. Which is also not guaranteed.  I am hoping for the best results as a significant long term investor.  But time and execution will determine how well the company does.  It’s been a bit of a rollercoaster and I would prefer to have the ride be more like a rocket ship.

StockTwits for iOS

 so many successful FDA approvals end up not working out as intended look at ICU for an example of that.  I know it’s a medical device versus what NRXP is doing.  Addressable market doesn’t guarantee an approval results in capturing the that entire market.  Too many variables to understand exact market share post award. Which is also not guaranteed.  I am hoping for the best results as a significant long term investor.  But time and execution will determine how well the company does.  It’s been a bit of a rollercoaster and I would prefer to have the ride be more like a rocket ship.

Dave

@ddimlich True, but it&#39;s not every day that the FDA (hopefully) hands you a monopoly in an existing market, we know supply is low, and the hospital suppliers already expressed interest. You never know, but this is an unusually good setup.

William C. Buckles

 True, but it's not every day that the FDA (hopefully) hands you a monopoly in an existing market, we know supply is low, and the hospital suppliers already expressed interest. You never know, but this is an unusually good setup.

@DavidBG @ddimlich theoretically yes.  Did Javitt pick a 2 or 3 year expiration date?  We all assume it will make a 3 year because of the timing, but the 30 month may have proven that it won’t make 36 months which forced them to go with a 24 month expiration.

So many questions left to be answered.  For instance why is someone shorting the hell out of the stock right now?  At such a low valuation???  What do they know?  Is it just a hedge?

Have there been any commercialization offers?

Why is the FDA slow rolling the data set response?  How big of a role did Makary play in the mental health push.

Was Javitt pretending to have connections or does he actually have them?  He certainly pissed off that Rockefeller guy.

Beef eater

 theoretically yes.  Did Javitt pick a 2 or 3 year expiration date?  We all assume it will make a 3 year because of the timing, but the 30 month may have proven that it won’t make 36 months which forced them to go with a 24 month expiration.

So many questions left to be answered.  For instance why is someone shorting the hell out of the stock right now?  At such a low valuation???  What do they know?  Is it just a hedge?

Have there been any commercialization offers?

Why is the FDA slow rolling the data set response?  How big of a role did Makary play in the mental health push.

Was Javitt pretending to have connections or does he actually have them?  He certainly pissed off that Rockefeller guy.

Jenga Master

@jonny80s @ddimlich So many questions, yes, but by and large, they&#39;ve already been answered. Your FUD about shelf stability is no more connected to reality than ever. Naked short interest was disclosed years ago, and the manipulation has been ongoing since then. A commercialization offer was mentioned a while ago, and the decision to build up management for sales shows that NRXP believes it can do better. Dr. Javitt said on the call that the timing of the response to the protocol proposal was linked to regulatory clocks. Etc.

 So many questions, yes, but by and large, they've already been answered. Your FUD about shelf stability is no more connected to reality than ever. Naked short interest was disclosed years ago, and the manipulation has been ongoing since then. A commercialization offer was mentioned a while ago, and the decision to build up management for sales shows that NRXP believes it can do better. Dr. Javitt said on the call that the timing of the response to the protocol proposal was linked to regulatory clocks. Etc.